Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in J Clin Oncol

Retrieve available abstracts of 48 articles:
HTML format
Text format



Single Articles


    April 2018
  1. VENOOK AP
    Advances in Adjuvant Therapy for Colon Cancer: P value or Practical Value.
    J Clin Oncol. 2018 Apr 5:JCO2018778423. doi: 10.1200/JCO.2018.77.8423.
    PubMed     Text format    


  2. ANDRE T, Vernerey D, Mineur L, Bennouna J, et al
    3 Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial.
    J Clin Oncol. 2018 Apr 5:JCO2017760355. doi: 10.1200/JCO.2017.76.0355.
    PubMed     Text format     Abstract available


  3. SOBRERO A, Lonardi S, Rosati G, Di Bartolomeo M, et al
    FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial.
    J Clin Oncol. 2018 Apr 5:JCO2017762187. doi: 10.1200/JCO.2017.76.2187.
    PubMed     Text format     Abstract available


    March 2018
  4. SUN R, Horiguchi M, Wei LJ
    Interpreting the Benefit of Trifluridine/Tipiracil in Metastatic Colorectal Cancer With Respect to Progression-Free Survival and Overall Survival.
    J Clin Oncol. 2018 Mar 20:JCO2017775643. doi: 10.1200/JCO.2017.77.5643.
    PubMed     Text format    


    February 2018
  5. FADELU T, Zhang S, Niedzwiecki D, Ye X, et al
    Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance).
    J Clin Oncol. 2018 Feb 28:JCO2017755413. doi: 10.1200/JCO.2017.75.5413.
    PubMed     Text format     Abstract available


    January 2018
  6. OVERMAN MJ, Lonardi S, Wong KYM, Lenz HJ, et al
    Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer.
    J Clin Oncol. 2018 Jan 20:JCO2017769901. doi: 10.1200/JCO.2017.76.9901.
    PubMed     Text format     Abstract available


  7. APARICIO T, Ghiringhelli F, Boige V, Le Malicot K, et al
    Bevacizumab Maintenance Versus No Maintenance During Chemotherapy-Free Intervals in Metastatic Colorectal Cancer: A Randomized Phase III Trial (PRODIGE 9).
    J Clin Oncol. 2018 Jan 18:JCO2017752931. doi: 10.1200/JCO.2017.75.2931.
    PubMed     Text format     Abstract available


  8. KENZIK KM, Balentine C, Richman J, Kilgore M, et al
    New-Onset Cardiovascular Morbidity in Older Adults With Stage I to III Colorectal Cancer.
    J Clin Oncol. 2018 Jan 16:JCO2017749739. doi: 10.1200/JCO.2017.74.9739.
    PubMed     Text format     Abstract available


    December 2017
  9. BUTOW PN, Turner J, Gilchrist J, Sharpe L, et al
    Randomized Trial of ConquerFear: A Novel, Theoretically Based Psychosocial Intervention for Fear of Cancer Recurrence.
    J Clin Oncol. 2017;35:4066-4077.
    PubMed     Text format     Abstract available


  10. XU J, Kim TW, Shen L, Sriuranpong V, et al
    Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA Study.
    J Clin Oncol. 2017 Dec 7:JCO2017743245. doi: 10.1200/JCO.2017.74.3245.
    PubMed     Text format     Abstract available


    November 2017
  11. WHITNEY RL, Bell JF, Tancredi DJ, Romano PS, et al
    Hospitalization Rates and Predictors of Rehospitalization Among Individuals With Advanced Cancer in the Year After Diagnosis.
    J Clin Oncol. 2017;35:3610-3617.
    PubMed     Text format     Abstract available


    August 2017
  12. DOTAN E, Cohen SJ, Starodub AN, Lieu CH, et al
    Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients With Refractory or Relapsing Metastatic Colorectal Cancer.
    J Clin Oncol. 2017 Aug 17:JCO2017739011. doi: 10.1200/JCO.2017.73.9011.
    PubMed     Text format     Abstract available


  13. IKOMA N, You YN, Bednarski BK, Rodriguez-Bigas MA, et al
    Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer.
    J Clin Oncol. 2017;35:2631-2638.
    PubMed     Text format     Abstract available


  14. EBISCH RMF, Rutten DWE, IntHout J, Melchers WJG, et al
    Long-Lasting Increased Risk of Human Papillomavirus-Related Carcinomas and Premalignancies After Cervical Intraepithelial Neoplasia Grade 3: A Population-Based Cohort Study.
    J Clin Oncol. 2017;35:2542-2550.
    PubMed     Text format     Abstract available


  15. ESPENSCHIED CR, LaDuca H, Li S, McFarland R, et al
    Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.
    J Clin Oncol. 2017;35:2568-2575.
    PubMed     Text format     Abstract available


    July 2017
  16. KASTRINOS F, Uno H, Ukaegbu C, Alvero C, et al
    Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome.
    J Clin Oncol. 2017;35:2165-2172.
    PubMed     Text format     Abstract available


    June 2017
  17. BURRIS HA, Infante JR, Ansell SM, Nemunaitis JJ, et al
    Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors.
    J Clin Oncol. 2017;35:2028-2036.
    PubMed     Text format     Abstract available


  18. HUA X, Phipps AI, Burnett-Hartman AN, Adams SV, et al
    Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival.
    J Clin Oncol. 2017 Jun 15:JCO2017723569. doi: 10.1200/JCO.2017.72.3569.
    PubMed     Text format     Abstract available


    May 2017
  19. DANIELS MS, Bannon SA, Mork ME
    Frequency of Germline BRCA1/2 Mutations in Unselected Patients With Colorectal Cancer.
    J Clin Oncol. 2017 May 16:JCO2017727222. doi: 10.1200/JCO.2017.72.7222.
    PubMed     Text format    


  20. JONES JC, Renfro LA, Al-Shamsi HO, Schrock AB, et al
    Non-V600 BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer.
    J Clin Oncol. 2017 May 9:JCO2016714394. doi: 10.1200/JCO.2016.71.4394.
    PubMed     Text format     Abstract available


  21. VAN DE WAL M, Thewes B, Gielissen M, Speckens A, et al
    Efficacy of Blended Cognitive Behavior Therapy for High Fear of Recurrence in Breast, Prostate, and Colorectal Cancer Survivors: The SWORD Study, a Randomized Controlled Trial.
    J Clin Oncol. 2017 May 4:JCO2016705301. doi: 10.1200/JCO.2016.70.5301.
    PubMed     Text format     Abstract available


    April 2017
  22. GROOT KOERKAMP B, Sadot E, Kemeny NE, Gonen M, et al
    Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis.
    J Clin Oncol. 2017 Apr 20:JCO2016718346. doi: 10.1200/JCO.2016.71.8346.
    PubMed     Text format     Abstract available


  23. RENFRO LA, Goldberg RM, Grothey A, Sobrero A, et al
    Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancerologie Digestive Database.
    J Clin Oncol. 2017 Apr 17:JCO2016715771. doi: 10.1200/JCO.2016.71.5771.
    PubMed     Text format     Abstract available


  24. HAMADA T, Cao Y, Qian ZR, Masugi Y, et al
    Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.
    J Clin Oncol. 2017 Apr 13:JCO2016707547. doi: 10.1200/JCO.2016.70.7547.
    PubMed     Text format     Abstract available


    March 2017
  25. SUD A, Thomsen H, Sundquist K, Houlston RS, et al
    Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.
    J Clin Oncol. 2017 Mar 13:JCO2016709709. doi: 10.1200/JCO.2016.70.9709.
    PubMed     Text format     Abstract available


  26. GARG MK, Zhao F, Sparano JA, Palefsky J, et al
    Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).
    J Clin Oncol. 2017;35:718-726.
    PubMed     Text format     Abstract available


    February 2017
  27. LOBERG M, Holme O, Kalager M
    Aspirin, Colorectal Cancer, and Cause of Death: A Complex Landscape.
    J Clin Oncol. 2017;35:568-569.
    PubMed     Text format    


  28. SEPULVEDA AR, Hamilton SR, Allegra CJ, Grody W, et al
    Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology.
    J Clin Oncol. 2017 Feb 6:JCO2016719807. doi: 10.1200/JCO.2016.71.9807.
    PubMed     Text format     Abstract available


    January 2017
  29. YURGELUN MB, Kulke MH, Fuchs CS, Allen BA, et al
    Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
    J Clin Oncol. 2017 Jan 30:JCO2016710012. doi: 10.1200/JCO.2016.71.0012.
    PubMed     Text format     Abstract available


  30. CASADABAN L, Maker AV
    Can Colon Cancer Recurrence and Metastases Be Determined After Surgical Resection Using a Gene Expression Signature?
    J Clin Oncol. 2017 Jan 23:JCO2016711572. doi: 10.1200/JCO.2016.71.1572.
    PubMed     Text format    


    December 2016
  31. NAGTEGAAL ID, Knijn N, Hugen N, Marshall HC, et al
    Tumor Deposits in Colorectal Cancer: Improving the Value of Modern Staging-A Systematic Review and Meta-Analysis.
    J Clin Oncol. 2016 Dec 28:JCO2016689091.
    PubMed     Text format     Abstract available


  32. SPARANO JA, Lee JY, Palefsky J, Henry DH, et al
    Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial.
    J Clin Oncol. 2016 Dec 12:JCO2016691642.
    PubMed     Text format     Abstract available


  33. LOEHRER AP, Song Z, Haynes AB, Chang DC, et al
    Impact of Health Insurance Expansion on the Treatment of Colorectal Cancer.
    J Clin Oncol. 2016;34:4110-4115.
    PubMed     Text format     Abstract available


    September 2016
  34. CESPEDES FELICIANO EM, Kroenke CH, Meyerhardt JA, Prado CM, et al
    Metabolic Dysfunction, Obesity, and Survival Among Patients With Early-Stage Colorectal Cancer.
    J Clin Oncol. 2016 Sep 6. pii: JCO674473.
    PubMed     Text format     Abstract available


    August 2016
  35. SARGENT DJ, Andre T, Grothey A
    Further Evaluating the Benefit of Adjuvant Chemotherapy for Colon Cancer.
    J Clin Oncol. 2016 Aug 15. pii: JCO684886.
    PubMed     Text format    


  36. DALY LE, Ryan AM, Power DG
    Response to "Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer".
    J Clin Oncol. 2016 Aug 1. pii: JCO688010.
    PubMed     Text format    


    July 2016
  37. NIEDZWIECKI D, Frankel WL, Venook AP, Ye X, et al
    Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance).
    J Clin Oncol. 2016 Jul 18. pii: JCO654699.
    PubMed     Text format     Abstract available


    June 2016
  38. YAMANAKA T, Oki E, Yamazaki K, Yamaguchi K, et al
    12-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II/III Colon Cancer With Surgery Alone: The SUNRISE Study.
    J Clin Oncol. 2016 Jun 20. pii: JCO670414.
    PubMed     Text format     Abstract available


    May 2016
  39. BAINS SJ, Mahic M, Myklebust TA, Smastuen MC, et al
    Aspirin As Secondary Prevention in Patients With Colorectal Cancer: An Unselected Population-Based Study.
    J Clin Oncol. 2016 May 31. pii: JCO653519.
    PubMed     Text format     Abstract available


    April 2016
  40. RICCI R, Martini M, Cenci T, Antinori A, et al
    Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive.
    J Clin Oncol. 2016;34:e107-9.
    PubMed     Text format    


  41. HOCHSTER HS, Niedzwiecki D
    Big Data, Small Effects.
    J Clin Oncol. 2016;34:1170-1.
    PubMed     Text format    


  42. GASPAROTTO D, Rossi S, Campagna D, Scavina P, et al
    Imatinib-Sensitizing KIT Mutation in a Carney-Stratakis-Associated GI Stromal Tumor.
    J Clin Oncol. 2016;34:e99-e103.
    PubMed     Text format    


    March 2016
  43. VENTURINI F, Gambi V, Di Lernia S, Vanzulli A, et al
    Linitis Plastica of the Rectum As a Clinical Presentation of Metastatic Lobular Carcinoma of the Breast.
    J Clin Oncol. 2016;34:e54-6.
    PubMed     Text format    


    January 2016
  44. DEENEN MJ, Meulendijks D, Cats A, Sechterberger MK, et al
    Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis.
    J Clin Oncol. 2016;34:227-34.
    PubMed     Text format     Abstract available


  45. HEGARTY S, Shapiro PJ, Fang CY, Barsevick AM, et al
    Physical and mental functioning in colorectal cancer (CRC) survivors by work status.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  46. SMITH V, Danus S, Schnell M, Lindquist J, et al
    Colorectal cancer survivorship statistics: A Veterans Affairs Central Cancer Registry analysis.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  47. VAN LOON K, You YN, Hu CY, Francescatti AB, et al
    How clinicians make decisions regarding surveillance and treatment of colorectal cancer (CRC) patients.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  48. GOUGH K, Drosdowsky A, Russell L, Aranda S, et al
    A randomized controlled trial (RCT) of a supportive care package (SurvivorCare, SC) for survivors of colorectal cancer (CRC).
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: